About BioHermes
BioHermes is a company based in Wuxi (China) founded in 2007. BioHermes operates in a competitive market with competitors including SD Biosensor, Alveo Technologies, Anavasi Diagnostics, 1Drop Diagnostics and DiabetOmics, among others.
- Headquarter Wuxi, China
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biohermes.com
- Social LinkedIn X
Competitors of BioHermes
BioHermes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, Alveo Technologies, Anavasi Diagnostics, 1Drop Diagnostics and DiabetOmics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| alveotechnologies.com | 2014 | Alameda, United States | $63.61M | – | Cloud-powered POC MDx device | |
| anavasidx.com | 2020 | Seattle, United States | $6M | – | Molecular detectors for COVID-19 detection are manufactured. | |
| 1dropdx.com | 2012 | Neuchatel, Switzerland | $7.75M | – | Finger-prick point-of-care diagnostics are provided for biomarker testing. | |
| diabetomics.com | 2008 | Hillsboro, United States | $11M | 35 | Point-of-care tests for diabetes and women's health risks are developed. | |
| ptsdiagnostics.com | 1992 | Indianapolis, United States | – | 211 | Point-of-care diagnostic instruments are developed for disease testing. | |
| oxsed.com | 2020 | United Kingdom | – | 9 | Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology. | |
| luasdiagnostics.com | 2020 | Guildford, United Kingdom | $949,082 | 3 | Sensors and connected app are developed for diabetes management. |
Detailed competitors of BioHermes
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to BioHermes
10 companies that operate in the same segment as BioHermes (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioHermes
BioHermes was founded in 2007.
BioHermes is headquartered in Wuxi, China. It is registered at Wuxi, Jiangsu, China.
BioHermes develops and manufactures low-cost rapid diagnostic tests specializing in the diabetes patient and the Womens health markets. The company offers POC devices such as- HbA1c Analyzer with Voice Prompt (Boric Acid Affinity Chromatography), A1C EZ 2.0- a portable NGSP certified HbA1c analyzer, Urine Microalbumin Diagnostic Kit, etc. The device glycated hemoglobin detection system has obtained patent protection in nearly 20 countries such as China, the United States, Japan, Canada, South Africa, etc. The company offers the IGFBP-1 fFN - Insulin-like growth factor binding protein-1 Fetal fibronectin combo test quick check kit and Fetal Fibronectin (fFN) rapid immunochemistry test kit for measuring fFN levels in cervicovaginal secretion samples. The test is ISO certified.
BioHermes's top competitors include Alveo Technologies, SD Biosensor and 1Drop Diagnostics.